RecruitingPhase 2NCT07197905

Restoring Iron Deficiency in POTS

Restoring Iron Deficiency to Expand Blood Volume and Improve POTS

Sponsor

Vanderbilt University Medical Center

Enrollment

12 participants

Start Date

Nov 24, 2025

Study Type

INTERVENTIONAL

Conditions

POTS - Postural Orthostatic Tachycardia Syndrome

Summary

People with postural orthostatic tachycardia syndrome (POTS) often have low red blood cell volumes and low ferritin in their blood (a marker of iron storage in the body). The purpose of this pilot study is to investigate whether giving iron to people with POTS who have low ferritin levels will increase the red blood cell volume and improve POTS symptoms.

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 45 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Intravenous iron for people with pots - postural orthostatic tachycardia syndrome. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 45 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGIntravenous iron

The Intravenous iron infusion will be administered according to standard clinical care. The provider will choose the dosage and formulation of IV iron.